Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ expectations

Market news

26 January 2021

Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ expectations

Johnson & Johnson (JNJ) reported Q4 FY 2020 earnings of $1.86 per share (versus $1.88 per share in Q4 FY 2019), beating analysts’ consensus estimate of $1.83 per share.

The company’s quarterly revenues amounted to $22.500 bln (+8.7% y/y), beating analysts’ consensus estimate of $21.621 bln.

The company also issued upside guidance for FY 2021, projecting EPS of $9.25-$9.45 versus analysts’ consensus estimate of $9.00 and sales of $88.8-$90.0 bln versus analysts’ consensus estimate of $88.6 bln.

JNJ rose to $169.00 (+1.82%) in pre-market trading.

Company News: 3M (MMM) quarterly results beat analysts’ estimates

Italy's PM Conte officially resigns

Market Focus

Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimer

Open Demo Account & Personal Page

Personal area

support@teletradepartners.com

Risk Warning: Trading in the financial markets (including trading on margin) provides a wide range of opportunities and enables investors ready to take risks to make high profits, but it carries a potentially high level of risk of loss. Therefore, prior to trading you should take into careful consideration whether such operations are suitable for you in terms of your level of knowledge and financial situation.